Report Detail
Global Biopharmaceutical and Vaccines Market Growth (Status and Outlook) 2019-2024
- RnM3128215 |
- 14 March, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Other
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
According to this study, over the next five years the Biopharmaceutical and Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Biopharmaceutical and Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Biopharmaceutical and Vaccines market by product type, application, key companies and key regions.
This study considers the Biopharmaceutical and Vaccines value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Biopharmaceutical
Vaccine Production
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biopharmaceutical and Vaccines market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biopharmaceutical and Vaccines market by identifying its various subsegments.
Focuses on the key global Biopharmaceutical and Vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharmaceutical and Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Biopharmaceutical and Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Biopharmaceutical and Vaccines Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biopharmaceutical and Vaccines Market Size 2014-2024
- 2.1.2 Biopharmaceutical and Vaccines Market Size CAGR by Region
- 2.2 Biopharmaceutical and Vaccines Segment by Type
- 2.2.1 Biopharmaceutical
- 2.2.2 Vaccine Production
- 2.3 Biopharmaceutical and Vaccines Market Size by Type
- 2.3.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (2014-2019)
- 2.4 Biopharmaceutical and Vaccines Segment by Application
- 2.4.1 Pharmaceuticals Industry
- 2.4.2 Clinical Diagnosis
- 2.4.3 Scientific Research
- 2.4.4 Others
- 2.5 Biopharmaceutical and Vaccines Market Size by Application
- 2.5.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Application (2014-2019)
3 Global Biopharmaceutical and Vaccines by Players
- 3.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Players
- 3.1.1 Global Biopharmaceutical and Vaccines Market Size by Players (2017-2019)
- 3.1.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Players (2017-2019)
- 3.2 Global Biopharmaceutical and Vaccines Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceutical and Vaccines by Regions
- 4.1 Biopharmaceutical and Vaccines Market Size by Regions
- 4.2 Americas Biopharmaceutical and Vaccines Market Size Growth
- 4.3 APAC Biopharmaceutical and Vaccines Market Size Growth
- 4.4 Europe Biopharmaceutical and Vaccines Market Size Growth
- 4.5 Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth
5 Americas
- 5.1 Americas Biopharmaceutical and Vaccines Market Size by Countries
- 5.2 Americas Biopharmaceutical and Vaccines Market Size by Type
- 5.3 Americas Biopharmaceutical and Vaccines Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Biopharmaceutical and Vaccines Market Size by Countries
- 6.2 APAC Biopharmaceutical and Vaccines Market Size by Type
- 6.3 APAC Biopharmaceutical and Vaccines Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Biopharmaceutical and Vaccines by Countries
- 7.2 Europe Biopharmaceutical and Vaccines Market Size by Type
- 7.3 Europe Biopharmaceutical and Vaccines Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Biopharmaceutical and Vaccines by Countries
- 8.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type
- 8.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Biopharmaceutical and Vaccines Market Forecast
- 10.1 Global Biopharmaceutical and Vaccines Market Size Forecast (2019-2024)
- 10.2 Global Biopharmaceutical and Vaccines Forecast by Regions
- 10.2.1 Global Biopharmaceutical and Vaccines Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Biopharmaceutical and Vaccines Forecast by Type
- 10.8 Global Biopharmaceutical and Vaccines Forecast by Application
11 Key Players Analysis
- 11.1 Novartis
- 11.1.1 Company Details
- 11.1.2 Biopharmaceutical and Vaccines Product Offered
- 11.1.3 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Novartis News
- 11.2 Pfizer
- 11.2.1 Company Details
- 11.2.2 Biopharmaceutical and Vaccines Product Offered
- 11.2.3 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Pfizer News
- 11.3 Sanofi
- 11.3.1 Company Details
- 11.3.2 Biopharmaceutical and Vaccines Product Offered
- 11.3.3 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Sanofi News
- 11.4 Roche
- 11.4.1 Company Details
- 11.4.2 Biopharmaceutical and Vaccines Product Offered
- 11.4.3 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Roche News
- 11.5 Abbott
- 11.5.1 Company Details
- 11.5.2 Biopharmaceutical and Vaccines Product Offered
- 11.5.3 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Abbott News
- 11.6 Biogen Idec
- 11.6.1 Company Details
- 11.6.2 Biopharmaceutical and Vaccines Product Offered
- 11.6.3 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Biogen Idec News
- 11.7 Regeneron Pharmaceuticals
- 11.7.1 Company Details
- 11.7.2 Biopharmaceutical and Vaccines Product Offered
- 11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Regeneron Pharmaceuticals News
- 11.8 Alexion Pharmaceuticals
- 11.8.1 Company Details
- 11.8.2 Biopharmaceutical and Vaccines Product Offered
- 11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Alexion Pharmaceuticals News
- 11.9 Johnson and Johnson
- 11.9.1 Company Details
- 11.9.2 Biopharmaceutical and Vaccines Product Offered
- 11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Johnson and Johnson News
- 11.10 GlaxoSmithKline
- 11.10.1 Company Details
- 11.10.2 Biopharmaceutical and Vaccines Product Offered
- 11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 GlaxoSmithKline News
- 11.11 Merck
- 11.12 Lonza
- 11.13 Boehringer Ingelheim
- 11.14 Rentschler
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Biopharmaceutical and Vaccines . Industry analysis & Market Report on Biopharmaceutical and Vaccines is a syndicated market report, published as Global Biopharmaceutical and Vaccines Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Biopharmaceutical and Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
